The Alzheimer's Association International Conference (AAIC) 2026 spotlighted new findings and advancements lighting the way for dementia care. Mary Patterson, BrainCheck's VP of Clinical & Regulatory, shares these emerging developments as she recaps the conference takeaways and walks through five resounding themes shaping where the field is headed.
You’ll hear about:
- How patient targeting has become the field's biggest bottleneck and where using EHR data, or population analytics, can help solve this issue
- The shift from proving blood biomarkers work to deploying them in real-world practice, since this remains a massive challenge
- Diagnosis alone is not the end goal, but rather care planning moving forward should focus on managing a patient longitudinally, providing caregiver support, and delivering an effective cognitive care pathway
- Brief digital tools go further than simply being an alternative to paper-based tests, and discussion has shifted to these tools being leveraged to identify patients for biomarker evaluation
- The growing attention to lifestyle intervention and modifiable risk factors that play a significant role in prevention and early detection, highlighting a growing proactive approach to Alzheimer's care
You'll also get an exclusive Research Spotlight as Mary shares the three BrainCheck studies presented at AAIC 2026:
- The strong relationship between BrainCheck Assess and the Montreal Cognitive Assessment (MoCA)
- The improvement seen from BrainCheck's cognitive care plan, including in anxiety, depression, and activities of daily living and functioning
- Success with digital translation and adaptation of BrainCheck Assess™ across 5 European languages and how it supports scalability
Download Slides